ATE172641T1 - Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen - Google Patents

Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen

Info

Publication number
ATE172641T1
ATE172641T1 AT96909200T AT96909200T ATE172641T1 AT E172641 T1 ATE172641 T1 AT E172641T1 AT 96909200 T AT96909200 T AT 96909200T AT 96909200 T AT96909200 T AT 96909200T AT E172641 T1 ATE172641 T1 AT E172641T1
Authority
AT
Austria
Prior art keywords
fumagillol
derivatives
production
medicinal products
products against
Prior art date
Application number
AT96909200T
Other languages
English (en)
Inventor
Jean-Michel Molina
Francis Derouin
Original Assignee
Sanofi Sa
Assist Publ Hopitaux De Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Assist Publ Hopitaux De Paris filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE172641T1 publication Critical patent/ATE172641T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AT96909200T 1995-03-27 1996-03-26 Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen ATE172641T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9503549 1995-03-27

Publications (1)

Publication Number Publication Date
ATE172641T1 true ATE172641T1 (de) 1998-11-15

Family

ID=9477436

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909200T ATE172641T1 (de) 1995-03-27 1996-03-26 Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen

Country Status (25)

Country Link
US (1) US5900431A (de)
EP (1) EP0817626B1 (de)
JP (1) JP3260378B2 (de)
KR (1) KR100286920B1 (de)
CN (1) CN1072485C (de)
AP (1) AP646A (de)
AT (1) ATE172641T1 (de)
AU (1) AU706161B2 (de)
CA (1) CA2216623C (de)
CZ (1) CZ286821B6 (de)
DE (1) DE69600879T2 (de)
DK (1) DK0817626T3 (de)
EA (1) EA000150B1 (de)
ES (1) ES2128846T3 (de)
FR (1) FR06C0014I2 (de)
HU (1) HU224028B1 (de)
IS (1) IS2048B (de)
NO (1) NO315968B1 (de)
NZ (1) NZ304906A (de)
OA (1) OA10515A (de)
PL (1) PL183378B1 (de)
SK (1) SK283883B6 (de)
TR (1) TR199701048T1 (de)
UA (1) UA41446C2 (de)
WO (1) WO1996030010A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL183378B1 (pl) * 1995-03-27 2002-06-28 Assist Publ Hopitaux De Paris Zastosowanie fumagilolu i jego pochodnych do wytwarzania jelitowych środków przeciwinfekcyjnych
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
DK1156829T3 (da) * 1999-02-26 2007-09-10 Sanofi Aventis Stabil formulering indeholdende fumagillin
JP3265394B1 (ja) * 2001-03-14 2002-03-11 泰三 矢野 アクリル系樹脂手袋
DE10341887A1 (de) * 2003-09-09 2005-03-31 Leopold Kostal Gmbh & Co. Kg Elektrisches Schaltermodul
FR2886855B1 (fr) * 2005-06-08 2009-07-17 Agronomique Inst Nat Rech Utilisation de la fumagilline et de ses derives pour augmenter la biodisponibilite des lactones macrocyliques
EP2217283A2 (de) * 2007-11-28 2010-08-18 Mersana Therapeutics, Inc. Biokompatible, biologisch abbaubare fumagillin-analogkonjugate
US8865746B2 (en) * 2008-07-18 2014-10-21 Zafgen, Inc. Methods of treating an overweight or obese subject
US8642650B2 (en) 2008-12-04 2014-02-04 Zafgen, Inc. Methods of treating an overweight or obese subject
US20120004162A1 (en) 2008-12-04 2012-01-05 Vath James E Methods of Treating an Overweight or Obese Subject
WO2013055385A2 (en) 2011-10-03 2013-04-18 Zafgen Corporation Methods of treating age related disorders
MX337575B (es) 2009-10-09 2016-03-10 Zafgen Corp Compuestos de sulfona y métodos para lafabricación y uso de éstos.
BR112012016793A2 (pt) 2010-01-08 2018-07-31 Zafgen Corp compostos tipo fumagilol e métodos de fazer e usar os mesmos
WO2011085198A1 (en) 2010-01-08 2011-07-14 Zafgen Corporation Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
WO2011127304A2 (en) 2010-04-07 2011-10-13 Zafgen Corporation Methods of treating an overweight subject
KR20130043207A (ko) 2010-07-22 2013-04-29 자프겐 인크. 트리시클릭 화합물 및 이의 제조 및 사용 방법
KR101892768B1 (ko) 2010-11-09 2018-08-28 자프겐 인크. Metap-2 저해제의 결정질 고체 및 그의 제조 및 이용 방법
WO2012075020A1 (en) 2010-11-29 2012-06-07 Zafgen Corporation Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
MX344238B (es) 2011-01-26 2016-12-07 Zafgen Inc Compuestos de tetrazol y métodos para preparar y usar los mismos.
CN103534244B (zh) 2011-03-08 2016-10-12 扎夫根股份有限公司 氧杂螺[2.5]辛烷衍生物及类似物
WO2012154678A1 (en) 2011-05-06 2012-11-15 Zafgen Corporation Tricyclic sulfonamide compounds and methods of making and using same
AU2012253760B2 (en) 2011-05-06 2016-02-04 Zafgen, Inc. Tricyclic pyrazole sulfonamide compounds and methods of making and using same
BR112013028534A2 (pt) 2011-05-06 2016-09-06 Zafgen Inc compostos tricíclicos parcialmente saturados e métodos para produção e utilização dos mesmos
AU2013209723B2 (en) 2012-01-18 2016-11-24 Zafgen, Inc. Tricyclic sulfonamide compounds and methods of making and using same
US9440943B2 (en) 2012-01-18 2016-09-13 Zafgen, Inc. Tricyclic sulfone compounds and methods of making and using same
US9260419B2 (en) 2012-05-07 2016-02-16 Zafgen, Inc. Polymorphic salt of a metap-2 inhibitor and methods of making and using same
CN104363905A (zh) 2012-05-08 2015-02-18 扎夫根股份有限公司 用metap2抑制剂治疗下丘脑性肥胖
EP2850079B1 (de) 2012-05-09 2018-05-02 Zafgen, Inc. Fumigillol derivate,verfahren zu deren herstellung und deren verwendung
MX2015005733A (es) 2012-11-05 2016-02-10 Zafgen Inc Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
AU2013337282A1 (en) 2012-11-05 2015-05-21 Zafgen, Inc. Tricyclic compounds and methods of making and using same
NZ707773A (en) 2012-11-05 2019-05-31 Zafgen Inc Methods of treating liver diseases
EP2968250B1 (de) 2013-03-14 2019-06-19 Zafgen, Inc. Verfahren zur behandlung von nierenerkrankungen und anderen störungen
CN106432255A (zh) 2015-08-11 2017-02-22 扎夫根公司 烟曲霉素醇螺环化合物和制备和使用其的方法
AR105671A1 (es) 2015-08-11 2017-10-25 Zafgen Inc Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
CN106591389B (zh) * 2015-10-15 2019-10-11 中国科学院微生物研究所 一种利用烟曲霉菌生产烟曲霉素的方法
CN105622593B (zh) * 2016-02-25 2018-06-26 中国农业科学院蜜蜂研究所 一种烟曲霉素的提取方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2791530A (en) * 1953-08-31 1957-05-07 Abbott Lab Stabilized fumagillin compositions
JPH0629278B2 (ja) * 1985-06-26 1994-04-20 藤沢薬品工業株式会社 オキサスピロオクタン化合物
US5135920A (en) * 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
EP0541716A1 (de) * 1990-07-27 1993-05-19 Repligen Corporation Neuartige methoden und zusammensetzungen zur behandlung von gefässerkrankungen
US5328930A (en) * 1993-03-01 1994-07-12 Emory University Treatment of microsporidial and acanthamoeba keratoconjunctivitis with topical fumagillin
PL183378B1 (pl) * 1995-03-27 2002-06-28 Assist Publ Hopitaux De Paris Zastosowanie fumagilolu i jego pochodnych do wytwarzania jelitowych środków przeciwinfekcyjnych
EP0799616A1 (de) * 1996-04-01 1997-10-08 Takeda Chemical Industries, Ltd. Orale Zubereitung enthaltend ein Fumagillolderivat
CA2210600A1 (en) * 1996-07-17 1998-01-17 Takashi Houkan Inhibitor of tumor metastasis or recurrence
WO1998005293A2 (en) * 1996-08-02 1998-02-12 The Children's Medical Center Corporation Method of regulating the female reproductive system through angiogenesis inhibitors

Also Published As

Publication number Publication date
HUP9801220A3 (en) 2001-10-29
CA2216623C (en) 2005-05-31
ES2128846T3 (es) 1999-05-16
EP0817626A2 (de) 1998-01-14
NO315968B1 (no) 2003-11-24
CZ304997A3 (en) 1997-12-17
UA41446C2 (uk) 2001-09-17
FR06C0014I2 (de) 2006-12-29
CN1179715A (zh) 1998-04-22
WO1996030010A2 (fr) 1996-10-03
CN1072485C (zh) 2001-10-10
EA000150B1 (ru) 1998-10-29
SK130797A3 (en) 1998-03-04
FR06C0014I1 (de) 2006-11-17
CA2216623A1 (en) 1996-10-03
HU224028B1 (hu) 2005-05-30
CZ286821B6 (en) 2000-07-12
SK283883B6 (sk) 2004-04-06
AU706161B2 (en) 1999-06-10
JPH11506421A (ja) 1999-06-08
AP9701092A0 (en) 1997-10-31
AU5278696A (en) 1996-10-16
NO974466D0 (no) 1997-09-26
IS4557A (is) 1997-09-11
EP0817626B1 (de) 1998-10-28
US5900431A (en) 1999-05-04
IS2048B (is) 2005-09-15
HUP9801220A2 (hu) 1999-09-28
EA199700267A1 (ru) 1998-04-30
PL322470A1 (en) 1998-02-02
DE69600879T2 (de) 1999-06-02
DK0817626T3 (da) 1999-07-12
AP646A (en) 1998-04-27
TR199701048T1 (xx) 1998-01-21
PL183378B1 (pl) 2002-06-28
WO1996030010A3 (fr) 1996-11-28
JP3260378B2 (ja) 2002-02-25
KR19980703271A (ko) 1998-10-15
OA10515A (fr) 2002-04-24
NZ304906A (en) 1999-06-29
KR100286920B1 (ko) 2001-04-16
DE69600879D1 (de) 1998-12-03
NO974466L (no) 1997-09-26
MX9707150A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
ATE172641T1 (de) Verwendung von fumagillol und seinen derivaten zur herstellung von arzneimitteln gegen darminfektionen
DE69623992D1 (de) Derivate von dolestatin, deren herstellung und verwendung
ATE283264T1 (de) Zwischenprodukte zur herstellung von metallproteinasehemmern
FI951439A0 (fi) Mikro-organismit tryptofaanin tuottamista varten ja näiden valmistusmenetelmät
DE69907698D1 (de) Azetidinderivate, deren herstellung und sie enthaltende arzneimittel
DE69427970D1 (de) Medikament gegen atopische krankheiten
DE69414885T2 (de) Gasdichter Film und Herstellung desselben
DE69520208D1 (de) Herstellung von nicht-zeolithischen molekularsieben
DE69203958T2 (de) Produktionssystem zur Herstellung von Kleidung und anderen Produkten.
DE69725326D1 (de) Herstellung von fugizides chinazolinonen und nützliche zwischenprodukte
DE69625857D1 (de) Siliconderivate, ihre Herstellung und Verwendung
ATE269077T1 (de) Verwendung von tetrahydropyridinderivaten zur herstellung von arzneimitteln zur behandlung demyelinisierender erkrankungen
NO962231L (no) Prolegemidler av paclitaxelderivater
ATE212034T1 (de) Derivate von 5-0-desosaminyl-6-0-methyl erythronolid a, ihre verfahren zur herstellung und verwendung zur herstellung von arzneimitteln
DE69421172D1 (de) Synthetises detergensstueck und herstellung davon
DE59611111D1 (de) Phospholipid-derivate von phosphonocarbonsäuren, deren herstellung sowie deren verwendung als antivirale arzneimittel
DE69108143T2 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
ATA56194A (de) Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
FI950389A0 (fi) Ny medicinsk anvaendning av hemiprodukter
DE69623986D1 (de) Herstellung von Allomelanin
DE69208096T2 (de) Herstellung von dialkyltellur und dialkylselen
DE59606492D1 (de) Herstellung von Poly-o-hydroxyamiden und Poly-o-mercaptoamiden
DE69509259D1 (de) Herstellung von glasfaserprodukten
DE69521142D1 (de) 6-methoxy-1h-benzotriazol-5-carboxamid-derivate, verfahren zur herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification